Technology | Simulators
Laerdal Medical, provider of simulation solutions for healthcare, and SonoSim Inc., provider of ultrasound education and training, announced the commercial release of the Laerdal-SonoSim Ultrasound Solution for SimMan3G and SimMom.
February 17, 2016
News | Cardiovascular Business
The Centers for Medicare & Medicaid Services (CMS) and America’s Health Insurance Plans (AHIP), as part of a broad Core Quality Measures Collaborative of healthcare system participants, released seven sets of clinical quality measures. These measures support multi-payer alignment, for the first time, on core measures primarily for physician quality programs. This work is informing CMS’s implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) through its measure development plan and required rulemaking.
February 17, 2016News | Remote Monitoring
Increasingly patients and providers are interested in using remote monitoring devices to help with their healthcare. Researchers at the University of California Los Angeles (UCLA) sought to determine if these devices could be useful in preventing 180-day all-cause hospital readmissions for heart failure patients.
February 17, 2016Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology | Stents Peripheral
Biotronik announced a partnership with Maquet Medical Systems USA to distribute Biotronik peripheral vascular devices in the United States.
February 17, 2016
News | Leads Implantable Devices
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the first-to-market MultiPoint Pacing technology featured on the Quadra line of cardiac resynchronization therapy defibrillators (CRT-D) and pacemakers.
February 17, 2016
News | Renal Denervation
February 17, 2016 — Up to 10 percent of people with high blood pressure have resistant hypertension — high blood ...
February 17, 2016Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Magnetic Resonance Imaging (MRI) | Dave Fornell and Jeff Zagoudis
For decades now, magnetic resonance imaging (MRI) has been noted for its excellent soft tissue imaging capability with ...
February 17, 2016News | Cardiac Diagnostics
Apervita Inc. announced the American College of Cardiology (ACC) will add a recognized tool for predicting atherosclerotic cardiovascular disease (ASCVD) to the growing body of analytics being distributed through the Apervita Marketplace.
February 16, 2016
News | Stem Cell Therapies
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin-Madison have generated master heart cells — primitive progenitors that form the developing heart.
February 16, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Cardiovascular Ultrasound | Jeff Zagoudis and Dave Fornell
(Read a 2018 update on cardiac ultrasound technologies "Recent Advances in Echocardiography Technology") There were some ...
February 12, 2016
News | Ultrasound Imaging
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) used ultrasound-activated microbubbles to improve preservation of heart muscle and function in a pig heart attack model. Based on this success, the method is now in phase I human clinical trials.
February 11, 2016
Technology | Patient Monitors
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new technology that monitors patients undergoing magnetic resonance imaging (MRI).
February 11, 2016Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Valve Technology
February 10, 2016 — Fred Hoiberg, head coach of the National Basketball Assocation’s (NBA) Chicago Bulls, is launching a ...
February 10, 2016
Feature | Cardiovascular Business | Dave Fornell
After five years of almost constant lobbying efforts and numerous attempts by the U.S. House to push through a repeal of ...
February 10, 2016
News | Stents
CeloNova BioSciences Inc. announced this week that the first patient has been enrolled in its COBRA REDUCE trial. The COBRA REDUCE trial recently received conditional U.S. Food and Drug Administration (FDA) approval and will study the Cobra PzF nanocoated coronary stent (NCS) system in patients at high risk of bleeding.
February 10, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now